(PharmaNewsWire.Com, September 03, 2021 ) The medication oxytocin, which is produced from the peptide of the same name and sold under the brand name Pitocin, is routinely used on women during labour to stimulate contractions. This can not only speed up labour and cut down on delivery time, but it can help stop bleeding after delivery. It is almost always given to patients as an injection into a vein or muscle. The medicine, however, is not without negative effects, the most dangerous of which is excessive uterine contractions after overconsumption, which could jeopardise the health of the baby. Other adverse effects include nausea and a slowed heart rate. Oxytocin has also been linked to allergic reactions, such as anaphylaxis. The medicine is still deemed to be extremely safe to use and is included in the WHO's List of Essential Medicines. Oxytocin can also be used as a medicine to help the mother become ready to nurse. The medicine has the ability to increase the production of breast milk, which is important for moms who are unable to do so naturally.
The growing tendency of giving birth in hospitals rather than at home, as well as the rising number of caesarean surgeries, are driving the expansion of the oxytocic medicines industry. Furthermore, the oxytocic pharmaceuticals industry is competitive due to the many types of goods offered by various firms linked to oxytocic medications in order to acquire market share. The primary issues limiting the growth of the oxytocic pharmaceutical industry are the negative effects associated with oxytocic medications that cause excessive bleeding following vaginal birth due to postpartum haemorrhage.
The Oxytocic Pharmaceuticals market study includes regional analysis for North America, Europe, Asia Pacific, and the Rest of the World. The Oxytocic Pharmaceuticals market is split further for major nations such as the United States, Canada, Germany, the United Kingdom, France, Italy, China, India, Japan, Brazil, South Africa, and others in each region.
We are a growth partnership company that provides fact-based consulting services focused on helping our clients achieve incremental and transformational growth competing in business-to- business and business-to- consumer markets. We facilitate their growth journey through an environment that is dominated by accelerating change, constant evolution of new business models, disruptive trends and technologies in their respective industry.
We serve a wide spectrum of global industries such as Semiconductor and Electronics, Information Technology, Communication, Medical Devices, Pharmaceuticals, Defense, Aviation, and Chemicals among others. Our well-seasoned blend of technical and marketing expertise enables us to serve our customers with comprehensive study of global supply chains that helps them to devise highly effective strategies.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: